← Browse by Condition
Medical Condition

renal transplantation

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 1

ClinicalMetric tracks all active clinical trials for renal transplantation sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — renal transplantation Clinical Trials

How many clinical trials are currently recruiting for renal transplantation?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for renal transplantation, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for renal transplantation?
renal transplantation research spans Phase 1 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a renal transplantation clinical trial?
Eligibility criteria for renal transplantation trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Top Sponsors
Assistance Publique - Hôpitaux de Paris 2 trials
Sakarya University 1 trial
Akdeniz University 1 trial
Qianfoshan Hospital 1 trial

Recruiting Clinical Trials

NCT06406179
Recruiting
Evaluation of the Efficacy of Dd-cfDNA in Routine Patient Care in Kidney Transplant Recipients"
Enrollment
500 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
View Trial →
NCT07533669
Recruiting
Effect of a Preoperative Sensory Modulation Room on Pain, Anxiety, and Sleep in Kidney Transplant Patients
Enrollment
40 pts
Location
Turkey (Türkiye)
Sponsor
Sakarya University
View Trial →
NCT06026592
Recruiting
Detection of Plasma DNA of Renal Origin in Kidney Transplant Patients
Enrollment
30 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
View Trial →
NCT07294183
Recruiting
The Effect of Emotion-Focused Intervention on Emotion Regulation and Well-Being of Individuals With Transplantation
Enrollment
56 pts
Location
Turkey (Türkiye)
Sponsor
Akdeniz University
View Trial →
NCT07045467 Phase 1
Recruiting
Remimazolam Infusion in Kidney Transplant Patients: A Multicenter Study
Enrollment
30 pts
Location
China
Sponsor
Qianfoshan Hospital
View Trial →

Related Conditions

transplant donation (1) donor nephrectomy (1) acute kidney injury (1) chronic kidney diseases (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology